2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Breast Neoplasms
10
Colorectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
7
Pancreatic Neoplasms
5
Neoplastic Cells, Circulating
4
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Prostatic Neoplasms
3
Oropharyngeal Neoplasms
3
Neoplasm, Residual
3
Disease
3
Nevi and Melanomas
2
Neuroendocrine Tumors
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
NSCLC
2
Melanoma
2
Head and Neck Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Hepatocellular
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Smoking
1
Interventions
Doxorubicin
17
Ifosfamide
12
Radiotherapy
8
pazopanib
5
selinexor
4
pembrolizumab
4
Filgrastim
4
pegfilgrastim
3
Sirolimus
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Imatinib Mesylate
3
Etoposide
3
AZD 6244
3
fludarabine phosphate
2
brostallicin
2
X-Rays
2
Trabectedin
2
Specimen Handling
2
Sorafenib
2
Radiation Dose Hypofractionation
2
Radiation
2
Diathermy
2
Chemotherapy, Adjuvant
2
Biopsy
2
thymoglobulin
1
temsirolimus
1
tazemetostat
1
sotigalimab
1
sapanisertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neurofibrosarcoma
×
Liquid Biopsy
×
Clear all
NCT06515860
2026-01-09
NF1-TED
Boston Children's Hospital
Recruiting
1,000 enrolled